Freya Biosciences secures new investment to develop microbial immunotherapies for bacterial vaginosis

Freya Biosciences (Freya or the Company), a transatlantic biotech company specializing in women’s health, today announces a $10.4 million strategic investment from the Bill & Melinda Gates Foundation (the foundation) with $1.4 million additional financing from current investor Export and Investment Fund of Denmark (EIFO).

FDA clears Nova’s Stat Profile Prime Plus analyzer for micro capillary sample mode

Nova Biomedical is pleased to announce that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for a micro capillary sample mode on

May 17, 2024

Minnesota district court halts drug price transparency law

A Minnesota district court judge on Monday halted a state law designed to prevent major drug price increases after the generic drug industry group known

December 7, 2023

Goodness Growth GDNSF stock analysis & why GDNSF stock may go up long term

September 12, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.